FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.2  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module
    771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    1 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Memantine 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Levocetirizine 5mg tablets (Bristol Laboratories Ltd) 60 tablet 6 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Levocetirizine 5mg tablets (Bristol Laboratories Ltd) 60 tablet 6 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Letrozole 2.5mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Letrozole 2.5mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Olanzapine 2.5mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Olanzapine 2.5mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Olanzapine 5mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Olanzapine 5mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Olanzapine 10mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Olanzapine 10mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 10mg tablets (Sun Pharmaceutical Industries Europe B.V.) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 10mg tablets (Sun Pharmaceutical Industries Europe B.V.) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 8 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 8 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 5mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 5mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 56 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) 56 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Metronidazole 500mg tablets (Zentiva Pharma UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Metronidazole 500mg tablets (Zentiva Pharma UK Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 750mg tablets (Nexcape Pharmaceuticals Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 750mg tablets (Nexcape Pharmaceuticals Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 500mg tablets (Nexcape Pharmaceuticals Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 500mg tablets (Nexcape Pharmaceuticals Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 100mg tablets (Nexcape Pharmaceuticals Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 100mg tablets (Nexcape Pharmaceuticals Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Naproxen 250mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Naproxen 250mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Naproxen 500mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Naproxen 500mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Amiodarone 100mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amiodarone 100mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Amiodarone 200mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amiodarone 200mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Irbesartan 75mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Irbesartan 75mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Irbesartan 150mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Irbesartan 150mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Irbesartan 300mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Irbesartan 300mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Mebeverine 135mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Mebeverine 135mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Trazodone 50mg capsules (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Trazodone 50mg capsules (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Trazodone 150mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Trazodone 150mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Trazodone 100mg capsules (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Trazodone 100mg capsules (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Rabeprazole 10mg gastro-resistant tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Rabeprazole 10mg gastro-resistant tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Rabeprazole 20mg gastro-resistant tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Rabeprazole 20mg gastro-resistant tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Montelukast 10mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Montelukast 10mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Montelukast 4mg chewable tablets sugar free (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Montelukast 4mg chewable tablets sugar free (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Montelukast 5mg chewable tablets sugar free (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Montelukast 5mg chewable tablets sugar free (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 10mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 10mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Anagrelide 500microgram capsules (Sandoz Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Anagrelide 500microgram capsules (Sandoz Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Metronidazole 500mg tablets (Zentiva Pharma UK Ltd) 21 tablet 3 x 7 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Metronidazole 500mg tablets (Zentiva Pharma UK Ltd) 21 tablet 3 x 7 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 750mg tablets (Nexcape Pharmaceuticals Ltd) 10 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 750mg tablets (Nexcape Pharmaceuticals Ltd) 10 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 500mg tablets (Nexcape Pharmaceuticals Ltd) 10 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 500mg tablets (Nexcape Pharmaceuticals Ltd) 10 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 500mg tablets (Nexcape Pharmaceuticals Ltd) 20 tablet 2 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 500mg tablets (Nexcape Pharmaceuticals Ltd) 20 tablet 2 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 500mg tablets (Nexcape Pharmaceuticals Ltd) 100 tablet 10 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 500mg tablets (Nexcape Pharmaceuticals Ltd) 100 tablet 10 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 100mg tablets (Nexcape Pharmaceuticals Ltd) 6 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 100mg tablets (Nexcape Pharmaceuticals Ltd) 6 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Naproxen 250mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Naproxen 250mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Naproxen 500mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Naproxen 500mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Amiodarone 100mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amiodarone 100mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Amiodarone 200mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amiodarone 200mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Irbesartan 75mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Irbesartan 75mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Irbesartan 150mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Irbesartan 150mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Irbesartan 300mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Irbesartan 300mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Mebeverine 135mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Mebeverine 135mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Trazodone 50mg capsules (Bristol Laboratories Ltd) 84 capsule 6 x 14 capsules Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Trazodone 50mg capsules (Bristol Laboratories Ltd) 84 capsule 6 x 14 capsules Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Trazodone 150mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Trazodone 150mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier

    Start Previous Page 325 of 342 Next End

    This concept is not in any reference sets

    Back to Start